Clinical trial AZUR-2 219606
A Phase 3, Double-Arm, Open-Label Study of Peri-operative Dostarlimab Monotherapy versus standard of care in Participants with Untreated Stage II/III dMMR/MSI-H
| Cancers | |
|---|---|
| Organ | Multiple |
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | GSK |
| EudraCT Identifier | 2023-503265-27-00 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT05855200 |
| Last update |